Early research (Phase 1)Study completedNCT01082926
What this trial is testing
Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2
Who this might be right for
Anaplastic AstrocytomaAnaplastic EpendymomaAnaplastic Meningioma+11 more
City of Hope Medical Center 6